TECENTRIQ (atezolizumab) for Metastatic Non-small Cell Lung Cancer - Cancer Therapy Advisor

TECENTRIQ (atezolizumab) for Metastatic Non-small Cell Lung Cancer

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for TECENTRIQ (atezolizumab), indicated for metastatic non-small cell lung cancer.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 10: Use in Specific Populations
Slide 13: Clinical Pharmacology
Slide 17: Warnings and Precautions
Slide 23: Clinical Safety and Efficacy
Slide 31: Drug Storage and Supply
Slide 33: References

Next hm-slideshow in Lung Cancer